Policy & Regulation
Gilead, AWS Collaborate on Development and Delivery of New Medicines for Patients
29 November 2021 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has selected US-based technology company Amazon.com, Inc's (NASDAQ: AMZN) Amazon Web Services, Inc business as its preferred cloud provider, Amazon said.

Innovating on AWS and with the help of AWS experts and partners in healthcare and life sciences, Gilead provides its data scientists with the latest advances in machine learning and analytics.

These capabilities fuel data-driven decision making across the organization, from biomarker discovery through manufacturing and clinical trial recruitment, and deliver insights that can help Gilead refine its drug pipeline.

The company also relies on AWS to host all workloads for its enterprise resource planning transformation project to implement SAP S/4HANA.

Gilead said it is reimagining its bioinformatics compute infrastructure in the world's leading cloud.

The use of AWS's compute, machine learning, and database capabilities will support the analysis and integration of diverse genomics, imaging, and experimental datasets to support breakthroughs in how Gilead diagnoses and treats diseases.

For instance, by securely analyzing deidentified patient genomic data at scale on AWS to reveal patterns, Gilead can uncover insights on how people living with cancer respond to existing therapeutic options, potentially accelerating the discovery of new treatments.

Additionally, in its IT organization Gilead uses AWS to host all workloads for its ERP transformation project to implement SAP S/4HANA. These systems support business-critical processes in areas such as supply chain, finance, operations, and commercial sales across all therapeutic areas and business units.

Running these processes on AWS provides the foundation for Gilead's implementation of SAP S/4HANA. It also helps the company shorten hardware refresh cycles, increase testing and deployment agility, and gain visibility to improve business planning.

This is Gilead's first implementation of production-scale ERP systems in the cloud, and AWS provides the company's IT transformation team with scalable, secure, and high-performing infrastructure.

Working alongside AWS, Gilead will integrate its SAP environments with a wide range of advanced AWS technologies in areas such as analytics and machine learning, uncovering business value and driving innovation.

Moving forward, with AWS as the foundation of its new cloud-based SAP environment, the company will use a variety of Amazon Elastic Compute Cloud (Amazon EC2) instance types, including X1 and X1e instances built for high-performance databases, in-memory databases, and other memory-intensive enterprise applications, to run ERP workloads more efficiently.

In addition, Gilead has moved more than 50% of its data center footprint to AWS over the past 12 months through an accelerated cloud migration program with AWS Professional Services.

The company also plans to migrate hundreds of applications to AWS, which include critical applications that support industry good practices guidelines and regulations in areas like drug manufacturing, storage, and distribution.

As a result, Gilead is accelerating its plans to upgrade its IT operations with AWS, while avoiding upfront costs to refresh hardware and the sustained costs of running an "always on," on-premises IT landscape provisioned for peak use.

As an additional element of the migration, the company is building an automated disaster recovery landscape in AWS. Doing so allows Gilead IT to optimize and scale its disaster recovery processes in the cloud to enhance resiliency.

With the help of AWS Professional Services and AWS experts in healthcare and life sciences, Gilead research and development teams are looking at ways to innovate in the cloud.
Login
Username:

Password:


Related Headlines